SCHEMBL2607308

SCHEMBL2607308

Cc1ccc(-c2nc3cncnc3n2-c2cccc3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.43
CYP1A2 P05177 5/20 0.43
CYP3A4 P08684 4/20 0.43
CYP2C9 P11712 3/20 0.43
HSD17B10 Q99714 2/20 0.43
MDM2 Q00987 1/20 0.42
USP2 O75604 3/20 0.40
CYP2C19 P33261 2/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 1/20 0.40
GLA P06280 1/20 0.40
MAPT P10636 1/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
CYP2D6 P10635 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30760997 0.84 CYP1A2 (0.43) ALDH1A1CYP1A2CYP3A4CYP2C9HSD17B10
SCHEMBL2618363 0.82 ALDH1A1 (0.52) ALDH1A1CYP2C9MDM2CYP2C19LMNA
SCHEMBL2602374 0.80 CYP1A2 (0.52) ALDH1A1CYP1A2CYP3A4CYP2C9HSD17B10
SCHEMBL3439911 0.79 ALDH1A1 (0.49) ALDH1A1CYP2C9HSD17B10MDM2USP2
SCHEMBL2607666 0.78 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4CYP2C9HSD17B10
SCHEMBL12626835 0.77 GSR (0.55) ALDH1A1CYP2C9MDM2CYP2C19LMNA
SCHEMBL3439908 0.77 ALDH1A1 (0.49) ALDH1A1CYP2C9MDM2CYP2C19LMNA
SCHEMBL2602436 0.76 ALDH1A1 (0.41) ALDH1A1CYP2C9MDM2CYP2C19MAPK1
SCHEMBL2607662 0.76 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4CYP2C9HSD17B10
SCHEMBL13998688 0.76 ALDH1A1 (0.43) ALDH1A1CYP2C9CYP2C19LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095027-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES SPELMAN COLLEGE (US) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095027-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES TYMP, MKI67, CCNI ALDH1A1 864/4885CYP1A2 1466/4885CYP3A4 641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.